Journey Medical (DERM) Receivables (2020 - 2026)
Journey Medical's (DERM) quarterly Receivables came in at $25.0 million in Q1 2026, up 38.65% YoY from $18.0 million in Q1 2025, and down 16.09% on a QoQ basis from $29.8 million in Q4 2025.
Journey Medical (DERM) Receivables (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Receivables data on file, last reported at $25.0 million in Q1 2026.
- Quarterly Receivables rose 38.65% year-over-year to $25.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.0 million (up 38.65% YoY) and the FY2025 annual result came in at $29.8 million, up 191.11% from the prior year.
- Receivables fell to $25.0 million in Q1 2026, from $29.8 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $31.2 million in Q1 2022 to a low of $8.0 million in Q3 2023.
- A 5-year average of $19.5 million and a median of $18.0 million in 2025 frame the typical range for Receivables.
- Annual changes were most pronounced in 2023 — Receivables plunged 72.0% — and 2025, when it surged 191.11%.
- Tracing DERM's Receivables over 5 years: stood at $28.2 million in 2022, then tumbled by 46.04% to $15.2 million in 2023, then tumbled by 32.79% to $10.2 million in 2024, then surged by 191.11% to $29.8 million in 2025, then decreased by 16.09% to $25.0 million in 2026.
- The last three Receivables figures came in at $25.0 million (Q1 2026), $29.8 million (Q4 2025), and $18.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.08 Bn |
| 10 | Journey Medical | 205.38 Mn | 179.73 Mn | 12.37 Mn | 36.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.25 Mn |
| Mar 31, 2026 | 24.99 Mn |
| Dec 31, 2025 | 29.78 Mn |
| Sep 30, 2025 | 17.98 Mn |
| Jun 30, 2025 | 15.64 Mn |
| Mar 31, 2025 | 18.03 Mn |
| Dec 31, 2024 | 10.23 Mn |
| Sep 30, 2024 | 10.67 Mn |
| Jun 30, 2024 | 10.47 Mn |
| Mar 31, 2024 | 9.80 Mn |
| Dec 31, 2023 | 15.22 Mn |
| Sep 30, 2023 | 7.99 Mn |
| Jun 30, 2023 | 16.74 Mn |
| Mar 31, 2023 | 27.62 Mn |
| Dec 31, 2022 | 28.21 Mn |
| Sep 30, 2022 | 28.53 Mn |
| Jun 30, 2022 | 28.67 Mn |
| Mar 31, 2022 | 31.18 Mn |
| Dec 31, 2021 | 23.11 Mn |
| Sep 30, 2021 | 31.74 Mn |